Similar Papers

Paper Title
Journal
Date
Author
In vitro pharmacodynamics of moxifloxacin versus levofloxacin against 4 strains of Streptococcus pneumoniae: 1 wild type, 2 first-step parC mutants, and 1 pump mutant
Jeremy Schafer ... John C Rotschafer
Diagnostic Microbiology & Infectious Disease | VOL. 60
Jeremy Schafer, et. al.Jeremy Schafer ... John C Rotschafer
30 Oct 2007
Evaluation of bacterial kill when modelling the bronchopulmonary pharmacokinetic profile of moxifloxacin and levofloxacin against parC-containing isolates of Streptococcus pneumoniae
C A Deryke
Journal of Antimicrobial Chemotherapy | VOL. 58
C A DerykeC A Deryke
01 Jul 2006
Quinolone resistance among pneumococci: therapeutic and diagnostic implications.
Donald E Low
Clinical Infectious Diseases | VOL. Suppl 38 4
Donald E LowDonald E Low
15 May 2004
Dual-targeting properties of the 3-aminopyrrolidyl quinolones, DC-159a and sitafloxacin, against DNA gyrase and topoisomerase IV: contribution to reducing in vitro emergence of quinolone-resistant Streptococcus pneumoniae
R Okumura ... T Otani
Journal of Antimicrobial Chemotherapy | VOL. 62
R Okumura, et. al.R Okumura ... T Otani
01 Apr 2008
View more papers

More From: Infectious Diseases in Clinical Practice

Paper Title
Journal
Date
Author
Three Strikes
Michael S Gelfand ... Kerry O Cleveland
Infectious Diseases in Clinical Practice | VOL. 33
Michael S Gelfand, et. al.Michael S Gelfand ... Kerry O Cleveland
22 Jan 2025
Images in ID
Laura E Felley ... Arick P Sabin
Infectious Diseases in Clinical Practice | VOL. 33
Laura E Felley, et. al.Laura E Felley ... Arick P Sabin
22 Jan 2025
Hematogenous Dissemination of Scedosporiosis in an Immunocompetent Patient
Steven Berger ... Mark Delman
Infectious Diseases in Clinical Practice | VOL. 33
Steven Berger, et. al.Steven Berger ... Mark Delman
22 Jan 2025
Early Predictive Value of Laboratory Inflammatory Markers in Evaluating Both Lung Involvement and Progression in Hospitalized Patients With COVID-19
Atefeh Barzegari ... Seyed Mostafa Baghaei Poor
Infectious Diseases in Clinical Practice | VOL. 33
Atefeh Barzegari, et. al.Atefeh Barzegari ... Seyed Mostafa Baghaei Poor
22 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.